Amy R. Dunn, B.S. - Related publications

Affiliations: 
Emory University, Atlanta, GA 
 The Jackson Laboratory, Bar Harbor, ME, United States 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
47 most relevant papers in past 60 days:
Year Citation  Score
2021 Threlfell S, Mohammadi AS, Ryan BJ, Connor-Robson N, Platt NJ, Anand R, Serres F, Sharp T, Bengoa-Vergniory N, Wade-Martins R, Ewing A, Cragg SJ, Brimblecombe KR. Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol. Frontiers in Cellular Neuroscience. 15: 658244. PMID 33935654 DOI: 10.3389/fncel.2021.658244   
2021 Vecchio LM, Sullivan P, Dunn AR, Bermejo MK, Fu R, Masoud ST, Gregersen E, Urs NM, Nazari R, Jensen PH, Ramsey A, Goldstein DS, Miller GW, Salahpour A. Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo. Journal of Neurochemistry. PMID 33991113 DOI: 10.1111/jnc.15432   
2021 Kramer DJ, Aisenberg EE, Kosillo P, Friedmann D, Stafford DA, Lee AY, Luo L, Hockemeyer D, Ngai J, Bateup HS. Generation of a DAT-P2A-Flpo mouse line for intersectional genetic targeting of dopamine neuron subpopulations. Cell Reports. 35: 109123. PMID 33979604 DOI: 10.1016/j.celrep.2021.109123   
2021 Downs AM, Fan X, Kadakia RF, Donsante Y, Jinnah HA, Hess EJ. Cell-intrinsic effects of TorsinA(ΔE) disrupt dopamine release in a mouse model of TOR1A dystonia. Neurobiology of Disease. 105369. PMID 33894367 DOI: 10.1016/j.nbd.2021.105369   
2021 Torres DJ, Yorgason JT, Mitchell CC, Hagiwara A, Andres MA, Kurokawa S, Steffensen SC, Bellinger FP. Selenoprotein P Modulates Methamphetamine Enhancement of Vesicular Dopamine Release in Mouse Nucleus Accumbens Via Dopamine D2 Receptors. Frontiers in Neuroscience. 15: 631825. PMID 33927588 DOI: 10.3389/fnins.2021.631825   
2021 Nunes C, Laranjinha J. Nitric oxide and dopamine metabolism converge via mitochondrial dysfunction in the mechanisms of neurodegeneration in Parkinson's disease. Archives of Biochemistry and Biophysics. 704: 108877. PMID 33864752 DOI: 10.1016/j.abb.2021.108877   
2021 Post MR, Sulzer D. The chemical tools for imaging dopamine release. Cell Chemical Biology. PMID 33894160 DOI: 10.1016/j.chembiol.2021.04.005   
2021 Estes MK, Bland JJ, Ector KK, Puppa MJ, Powell DW, Lester DB. A high fat western diet attenuates phasic dopamine release. Neuroscience Letters. 756: 135952. PMID 33979702 DOI: 10.1016/j.neulet.2021.135952   
2021 Macedo-Lima M, Remage-Healey L. Dopamine modulation of motor and sensory cortical plasticity among vertebrates. Integrative and Comparative Biology. PMID 33822047 DOI: 10.1093/icb/icab019   
2021 Buck SA, Steinkellner T, Aslanoglou D, Villeneuve M, Bhatte SH, Childers VC, Rubin SA, De Miranda BR, O'Leary EI, Neureiter EG, Fogle KJ, Palladino MJ, Logan RW, Glausier JR, Fish KN, et al. Vesicular glutamate transporter modulates sex differences in dopamine neuron vulnerability to age-related neurodegeneration. Aging Cell. e13365. PMID 33909313 DOI: 10.1111/acel.13365   
2021 Fernandes MF, Lau D, Sharma S, Fulton S. Anxiety-like behavior in female mice is modulated by STAT3 signaling in midbrain dopamine neurons. Brain, Behavior, and Immunity. PMID 33872705 DOI: 10.1016/j.bbi.2021.04.013   
2021 Ng J, Barral S, De La Fuente Barrigon C, Lignani G, Erdem FA, Wallings R, Privolizzi R, Rossignoli G, Alrashidi H, Heasman S, Meyer E, Ngoh A, Pope S, Karda R, Perocheau D, et al. Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism. Science Translational Medicine. 13. PMID 34011628 DOI: 10.1126/scitranslmed.aaw1564   
2021 Buck SA, Miranda BR, Logan RW, Fish KN, Greenamyre JT, Freyberg Z. VGLUT2 is a determinant of dopamine neuron resilience in a rotenone model of dopamine neurodegeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33893220 DOI: 10.1523/JNEUROSCI.2770-20.2021   
2021 Dakik H, Mantash S, Nehme A, Kobeissy F, Zabet-Moghaddam M, Mirzaei P, Mechref Y, Gaillard A, Prestoz L, Zibara K. Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease. Frontiers in Neuroscience. 15: 621121. PMID 33776636 DOI: 10.3389/fnins.2021.621121   
2021 Cui K, Yang F, Tufan T, Raza MU, Zhan Y, Fan Y, Zeng F, Brown RW, Price JB, Jones TC, Miller GW, Zhu MY. Restoration of Noradrenergic Function in Parkinson's Disease Model Mice. Asn Neuro. 13: 17590914211009730. PMID 33940943 DOI: 10.1177/17590914211009730   
2021 Yang SJ, Del Bonis-O'Donnell JT, Beyene AG, Landry MP. Near-infrared catecholamine nanosensors for high spatiotemporal dopamine imaging. Nature Protocols. PMID 34021297 DOI: 10.1038/s41596-021-00530-4   
2021 Hikima T, Lee CR, Witkovsky P, Chesler J, Ichtchenko K, Rice ME. Activity-dependent somatodendritic dopamine release in the substantia nigra autoinhibits the releasing neuron. Cell Reports. 35: 108951. PMID 33826884 DOI: 10.1016/j.celrep.2021.108951   
2021 Longo F, Mancini M, Ibraheem PL, Aryal S, Mesini C, Patel JC, Penhos E, Rahman N, Mamcarz M, Santini E, Rice ME, Klann E. Cell-type-specific disruption of PERK-eIF2α signaling in dopaminergic neurons alters motor and cognitive function. Molecular Psychiatry. PMID 33879865 DOI: 10.1038/s41380-021-01099-w   
2021 Aguilar JI, Cheng MH, Font J, Schwartz AC, Ledwitch K, Duran A, Mabry SJ, Belovich AN, Zhu Y, Carter AM, Shi L, Kurian MA, Fenollar-Ferrer C, Meiler J, Ryan RM, et al. Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia. Elife. 10. PMID 34002696 DOI: 10.7554/eLife.68039   
2021 Pavia-Collado R, Cóppola-Segovia V, Miquel-Rio L, Alarcón-Aris D, Rodríguez-Aller R, Torres-López M, Paz V, Ruiz-Bronchal E, Campa L, Artigas F, Montefeltro A, Revilla R, Bortolozzi A. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice. International Journal of Molecular Sciences. 22. PMID 33805843 DOI: 10.3390/ijms22062939   
2021 Schmack K, Bosc M, Ott T, Sturgill JF, Kepecs A. Striatal dopamine mediates hallucination-like perception in mice. Science (New York, N.Y.). 372. PMID 33795430 DOI: 10.1126/science.abf4740   
2021 Schaffernicht G, Shang Q, Stievenard A, Bötzel K, Dening Y, Kempe R, Toussaint M, Gündel D, Kranz M, Reichmann H, Vanbesien-Mailliot C, Brust P, Dieterich M, Funk RHW, Ravens U, et al. Pathophysiological Changes in the Enteric Nervous System of Rotenone-Exposed Mice as Early Radiological Markers for Parkinson's Disease. Frontiers in Neurology. 12: 642604. PMID 33841309 DOI: 10.3389/fneur.2021.642604   
2021 Gui H, Liu C, He H, Zhang J, Chen H, Zhang Y. Dopaminergic Projections From the Ventral Tegmental Area to the Nucleus Accumbens Modulate Sevoflurane Anesthesia in Mice. Frontiers in Cellular Neuroscience. 15: 671473. PMID 33994950 DOI: 10.3389/fncel.2021.671473   
2021 Müller T. Experimental Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of the Evidence. Journal of Experimental Pharmacology. 13: 397-408. PMID 33824605 DOI: 10.2147/JEP.S267032   
2021 Haque ME, Azam S, Akther M, Cho DY, Kim IS, Choi DK. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease. International Journal of Molecular Sciences. 22. PMID 33925146 DOI: 10.3390/ijms22094674   
2021 Hayashi J, Ton J, Negi S, Stephens DEKM, Pountney DL, Preiss T, Carver JA. The Effect of Oxidized Dopamine on the Structure and Molecular Chaperone Function of the Small Heat-Shock Proteins, αB-Crystallin and Hsp27. International Journal of Molecular Sciences. 22. PMID 33918165 DOI: 10.3390/ijms22073700   
2021 Saito J, Kojima T, Tanifuji S, Kato Y, Oka S, Ichikawa Y, Miyagi E, Tachibana T, Asou T, Yokoyama U. Transcriptome Analysis Reveals Differential Gene Expression between the Closing Ductus Arteriosus and the Patent Ductus Arteriosus in Humans. Journal of Cardiovascular Development and Disease. 8. PMID 33923468 DOI: 10.3390/jcdd8040045   
2021 Yan T, Mao Q, Zhang X, Wu B, Bi K, He B, Jia Y. Schisandra chinensis protects against dopaminergic neuronal oxidative stress, neuroinflammation and apoptosis the BDNF/Nrf2/NF-κB pathway in 6-OHDA-induced Parkinson's disease mice. Food & Function. 12: 4079-4091. PMID 33977962 DOI: 10.1039/d0fo02836c   
2021 Zhao J, Jaffe A, Li H, Lindenbaum O, Sefik E, Jackson R, Cheng X, Flavell RA, Kluger Y. Detection of differentially abundant cell subpopulations in scRNA-seq data. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34001664 DOI: 10.1073/pnas.2100293118   
2021 Sloley SS, Main BS, Winston CN, Harvey AC, Kaganovich A, Korthas HT, Caccavano AP, Zapple DN, Wu JY, Partridge JG, Cookson MR, Vicini S, Burns MP. High-frequency head impact causes chronic synaptic adaptation and long-term cognitive impairment in mice. Nature Communications. 12: 2613. PMID 33972519 DOI: 10.1038/s41467-021-22744-6   
2021 Pino JA, Nuñez-Vivanco G, Hidalgo G, Reyes Parada M, Khoshbouei H, Torres GE. Identification of Critical Residues in the Carboxy Terminus of the Dopamine Transporter Involved in the G Protein βγ-Induced Dopamine Efflux. Frontiers in Pharmacology. 12: 642881. PMID 33841159 DOI: 10.3389/fphar.2021.642881   
2021 Li L, Cheng L, Wang Y. Differential roles of two isoforms of dopamine D2 receptors in l-dopa-induced abnormal involuntary movements in mice. Neuroreport. 32: 555-561. PMID 33850083 DOI: 10.1097/WNR.0000000000001623   
2021 Björklund A, Parmar M. Dopamine Cell Therapy: From Cell Replacement to Circuitry Repair. Journal of Parkinson's Disease. PMID 33814467 DOI: 10.3233/JPD-212609   
2021 Pitzer E, Williams MT, Vorhees CV. Effects of pyrethroids on brain development and behavior: Deltamethrin. Neurotoxicology and Teratology. 106983. PMID 33848594 DOI: 10.1016/j.ntt.2021.106983   
2021 Wang HR, Hu SW, Zhang S, Song Y, Wang XY, Wang L, Li YY, Yu YM, Liu H, Liu D, Ding HL, Cao JL. KCNQ Channels in the Mesolimbic Reward Circuit Regulate Nociception in Chronic Pain in Mice. Neuroscience Bulletin. PMID 33900570 DOI: 10.1007/s12264-021-00668-x   
2021 Frings L, Henninger F, Treppner M, Köber G, Boeker M, Meyer PT. DAT SPECT Predicts Survival in Patients Assessed for Differential Diagnosis of Dementia. Journal of Alzheimer's Disease : Jad. PMID 33998542 DOI: 10.3233/JAD-210062   
2021 Shi L, Lin Y, Jiao Y, Herr SA, Tang J, Rogers E, Chen Z, Shi R. Acrolein scavenger dimercaprol offers neuroprotection in an animal model of Parkinson's disease: implication of acrolein and TRPA1. Translational Neurodegeneration. 10: 13. PMID 33910636 DOI: 10.1186/s40035-021-00239-0   
2021 Leung LS, Luo T. Cholinergic Modulation of General Anesthesia. Current Neuropharmacology. PMID 33882810 DOI: 10.2174/1570159X19666210421095504   
2021 Bekal M, Sun L, Ueno S, Moritake T. Neurobehavioral effects of acute low-dose whole-body irradiation. Journal of Radiation Research. PMID 33982114 DOI: 10.1093/jrr/rrab026   
2021 Ingram SM, Rana T, Manson AM, Yayah FM, Jackson EGB, Anderson C, Davids BO, Goodwin JS. Optogenetic-induced multimerization of the dopamine transporter increases uptake and trafficking to the plasma membrane. The Journal of Biological Chemistry. 100787. PMID 34015332 DOI: 10.1016/j.jbc.2021.100787   
2021 Awasthi AK, Gupta S, Namdev KR, Banerjee A, Srivastava A. Polydopamine and dopamine interfere with tetrazolium-based cytotoxicity assays and produce exaggerated cytocompatibility inferences. Biomaterials Science. PMID 33870966 DOI: 10.1039/d1bm00140j   
2021 Virlogeux A, Scaramuzzino C, Lenoir S, Carpentier R, Louessard M, Genoux A, Lino P, Hinckelmann MV, Perrier AL, Humbert S, Saudou F. Increasing brain palmitoylation rescues behavior and neuropathology in Huntington disease mice. Science Advances. 7. PMID 33789888 DOI: 10.1126/sciadv.abb0799   
2021 Liu X, Du ZR, Wang X, Luk KH, Chan CH, Cao X, Zhao Q, Zhao F, Wong WT, Wong KH, Dong XL. Colonic Dopaminergic Neurons Changed Reversely With Those in the Midbrain via Gut Microbiota-Mediated Autophagy in a Chronic Parkinson's Disease Mice Model. Frontiers in Aging Neuroscience. 13: 649627. PMID 33912026 DOI: 10.3389/fnagi.2021.649627   
2021 Langley MR, Ghaisas S, Palanisamy BN, Ay M, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG. Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson's disease. Experimental Neurology. 341: 113716. PMID 33839143 DOI: 10.1016/j.expneurol.2021.113716   
2021 He YB, Liu YL, Yang ZD, Lu JH, Song Y, Guan YM, Chen YM. Effect of ginsenoside-Rg1 on experimental Parkinson's disease: A systematic review and meta-analysis of animal studies. Experimental and Therapeutic Medicine. 21: 552. PMID 33850524 DOI: 10.3892/etm.2021.9984   
2021 Kish SJ, O'Leary G, Mamelak M, McCluskey T, Warsh JJ, Shapiro C, Bies R, Yu Y, Pollock B, Tong J, Boileau I. Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging study. Human Psychopharmacology. e2791. PMID 33899252 DOI: 10.1002/hup.2791   
2021 Lin Z, Liu C, Fan E, Zhang Y, Zheng S, Rao Y. An efficient and label-free LC-MS/MS method for assessing drug's activity at dopamine and serotonin transporters using transporter-transfected HEK293T cells. Journal of Psychopharmacology (Oxford, England). 2698811211008576. PMID 33888022 DOI: 10.1177/02698811211008576